The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease

M Amidfar, J de Oliveira, E Kucharska, J Budni, YK Kim - Life sciences, 2020 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia worldwide. β-amyloid
peptide (Aβ) is currently assumed to be the main cause of synaptic dysfunction and cognitive …

Nicotinic ACh receptors as therapeutic targets in CNS disorders

KT Dineley, AA Pandya, JL Yakel - Trends in pharmacological sciences, 2015 - cell.com
The neurotransmitter acetylcholine (ACh) can regulate neuronal excitability by acting on the
cys-loop cation-conducting ligand-gated nicotinic ACh receptor (nAChR) channels. These …

Aβ oligomers–a decade of discovery

DM Walsh, DJ Selkoe - Journal of neurochemistry, 2007 - Wiley Online Library
Converging lines of evidence suggest that progressive accumulation of the amyloid β‐
protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long …

Hippocampal neurogenesis: learning to remember

O Lazarov, C Hollands - Progress in neurobiology, 2016 - Elsevier
Alzheimer's disease, the most prevalent form of dementia in the elderly, is characterized by
progressive memory loss and cognitive dysfunction. It has become increasingly clear that …

[HTML][HTML] Nicotinic acetylcholine receptors in neurological and psychiatric diseases

AV Terry Jr, K Jones, D Bertrand - Pharmacological Research, 2023 - Elsevier
Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that are
widely distributed both pre-and post-synaptically in the mammalian brain. By modulating …

Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer's disease pathology and improves cognition in the 5XFAD mouse

MB Dinkins, J Enasko, C Hernandez, G Wang… - Journal of …, 2016 - jneurosci.org
Recent evidence implicates exosomes in the aggregation of Aβ and spreading of tau in
Alzheimer9s disease. In neural cells, exosome formation can be blocked by inhibition or …

Mouse models of Alzheimer's disease

AM Hall, ED Roberson - Brain research bulletin, 2012 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia, affecting 35 million people
today. The search for new treatments is made ever more urgent by prospects for increasing …

Alzheimer's disease: synaptic dysfunction and Aβ

GM Shankar, DM Walsh - Molecular neurodegeneration, 2009 - Springer
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a
strong correlation between the extent of synapse loss and the severity of dementia …

[HTML][HTML] Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model

F Calon, GP Lim, F Yang, T Morihara, B Teter, O Ubeda… - Neuron, 2004 - cell.com
Learning and memory depend on dendritic spine actin assembly and docosahexaenoic acid
(DHA), an essential n-3 (omega-3) polyunsaturated fatty acid (PFA). High DHA consumption …